EichorEICHOR
Study identifier: NCT05106387 Synced from ClinicalTrials.gov · August 10, 2026
● Study status: Recruiting

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Condition: Chronic Kidney Disease (CKD)  ·  Sponsor: Regeneron Pharmaceuticals

PhaseN/A
Planned participants20
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNoCheck eligibility criteria ↓
Where9 locations

Interested? Contact the study team ↓

For sponsors, CROs & site teams
Professional view of this study — listed sites, countries and recruiting context from the public registry. Everything below is written for patients and caregivers.Open the site landscape →

About this study

The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trials Administrator  ·  844-734-6643  ·  clinicaltrials@regeneron.com

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: 1. Received at least 1 dose of treatment with vonsetamig in study R5459-RT-1944 \[NCT05092347\]. 2. Received after acceptable crossmatching, a kidney transplant while enrolled in study R5459-RT-1944 3. Willing and able to comply with clinic visits and study-related procedures 4. Provide informed consent signed by study patient or legally acceptable representative Exclusion Criteria: 1.There are no exclusion criteria for this study. Note: Other protocol defined Inclusion/Exclusion criteria may apply

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (9)

Cedars-Sinai Medical CenterLos Angeles, California, United StatesRecruiting
University of California IrvineOrange, California, United StatesRecruiting
Connie Frank Transplant Center at UCSFSan Francisco, California, United StatesRecruiting
Yale University of MedicineNew Haven, Connecticut, United StatesCompleted
Comprehensive Transplant CenterChicago, Illinois, United StatesRecruiting
John Hopkins HospitalBaltimore, Maryland, United StatesRecruiting
University of MinnesotaMinneapolis, Minnesota, United StatesRecruiting
New York University Langone HealthNew York, New York, United StatesCompleted
Penn Transplant InstitutePhiladelphia, Pennsylvania, United StatesRecruiting

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

Los AngelesOrangeSan FranciscoChicago

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →